Application | Comment | Organism |
---|---|---|
drug development | the development of inhibitors against calpain-10 may be useful as therapeutic agents for a number of calpainopathies | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
N-[(2R)-4-hydroxy-1-oxobutan-2-yl]-N2-(phenylcarbamothioyl)-L-leucinamide | binding structure, the inhibitor shows interactions with the Cys115, Gly207, Gly20,8 and Gly271 residues, overview. Reversible intramolecular conversion of the cyclic hemiacetal form of SNJ-1715 to the free aldehyde form | Homo sapiens | |
N-[(3R)-2-hydroxytetrahydrofuran-3-yl]-N2-(phenylcarbamothioyl)-L-leucinamide | binding structure, the inhibitor shows interactions with the Cys115, Gly207, Gly20,8 and Gly271 residues, overview. Reversible intramolecular conversion of the cyclic hemiacetal form of SNJ-1715 to the free aldehyde form | Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | depedent on, activates | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9HC96 | gene CAPN10 | - |
Synonyms | Comment | Organism |
---|---|---|
calpain-10 | - |
Homo sapiens |
CAPN10 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | hyperactivation of the enzyme initiates a series of destructive cycles that can cause irreversible damage to cells | Homo sapiens |
metabolism | the enzyme is involved in diseases such as cancer, heart attack, and stroke, a role for the CAPN10 gene indiabetes mellitus type II | Homo sapiens |
additional information | three-dimensional enzyme homology modelling, structure comparisons, QM/MM molecular dynamics simulations, overview | Homo sapiens |